{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-063110","form_type":"8-K","ticker":"RDAC","cik":"0002018145","company_name":"Rising Dragon Acquisition Corp.","filed_at":"2026-06-01T10:08:35+00:00","discovered_at":"2026-06-01T10:10:00.263487+00:00","generated_at":"2026-06-01T10:10:10.962077+00:00","sec_items":["1.01","5.03","5.07","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Shareholders approve SPAC extension to Oct 15, 2027; ~1.9M shares redeemed","bullets":["Extension period extended 15 months to October 15, 2027 via monthly deposits.","Monthly extension fee set at $75,828.46 (lesser of $100k or $0.033/public share).","1,903,823 ordinary shares tendered for redemption at the extension meeting.","Second amended charter and trust agreement amendment filed effective May 28, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-063110","json":"https://secwatch.observer/filing/0001213900-26-063110.json","markdown":"https://secwatch.observer/filing/0001213900-26-063110.md","text":"https://secwatch.observer/filing/0001213900-26-063110.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2018145/000121390026063110/0001213900-26-063110-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2018145/000121390026063110/ea0292895-8k_rising.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T10:10:10.962077+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001437749-26-018930","ticker":"CPSH","company_name":"CPS TECHNOLOGIES CORP/DE/","filed_at":"2026-06-01T13:35:50+00:00","headline":"CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share","event_type":"other_material","sec_items":["1.01","5.03","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same SEC item: 1.01, 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-018930","json":"https://secwatch.observer/filing/0001437749-26-018930.json","markdown":"https://secwatch.observer/filing/0001437749-26-018930.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/0001437749-26-018930-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/cpsh20260528_8k.htm"},"side_by_side_evidence":null},{"accession":"0001104659-26-068614","ticker":"CLIR","company_name":"ClearSign Technologies Corp","filed_at":"2026-06-01T12:30:28+00:00","headline":"ClearSign Technologies prices 777,780-share public offering at $4.33/share for ~$3.37M gross proceeds","event_type":"other_material","sec_items":["1.01","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same SEC item: 1.01, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-068614","json":"https://secwatch.observer/filing/0001104659-26-068614.json","markdown":"https://secwatch.observer/filing/0001104659-26-068614.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434524/000110465926068614/0001104659-26-068614-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434524/000110465926068614/tm2615953d1_8k.htm"},"side_by_side_evidence":null},{"accession":"0000015847-26-000009","ticker":"BUKS","company_name":"BUTLER NATIONAL CORP","filed_at":"2026-06-01T16:41:32+00:00","headline":"CEO Christopher Reedy discloses ongoing cancer treatment; remains in role","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000015847-26-000009","json":"https://secwatch.observer/filing/0000015847-26-000009.json","markdown":"https://secwatch.observer/filing/0000015847-26-000009.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/15847/000001584726000009/0000015847-26-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/15847/000001584726000009/buks-20260601.htm"},"side_by_side_evidence":null},{"accession":"0001129928-26-000037","ticker":"ONCY","company_name":"ONCOLYTICS BIOTECH INC","filed_at":"2026-06-01T13:06:14+00:00","headline":"Oncolytics reports positive initial preclinical data for pelareorep + RAS inhibitors; further studies planned","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.45,"calibrated_materiality_score":0.45,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001129928-26-000037","json":"https://secwatch.observer/filing/0001129928-26-000037.json","markdown":"https://secwatch.observer/filing/0001129928-26-000037.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1129928/000112992826000037/0001129928-26-000037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1129928/000112992826000037/oncy-20260601.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-249684","ticker":"INAB","company_name":"IN8BIO, INC.","filed_at":"2026-06-01T10:56:36+00:00","headline":"IN8bio enters new ATM equity facility with JonesTrading, terminates prior Cantor agreement","event_type":"other_material","sec_items":["1.01","1.02","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 1.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-249684","json":"https://secwatch.observer/filing/0001193125-26-249684.json","markdown":"https://secwatch.observer/filing/0001193125-26-249684.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1740279/000119312526249684/0001193125-26-249684-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1740279/000119312526249684/d100941d8k.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-248897","ticker":"EAF","company_name":"GRAFTECH INTERNATIONAL LTD","filed_at":"2026-05-29T21:26:21+00:00","headline":"GrafTech enters into $50M at-the-market equity distribution agreement with Evercore","event_type":"other_material","sec_items":["1.01","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same SEC item: 1.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-248897","json":"https://secwatch.observer/filing/0001193125-26-248897.json","markdown":"https://secwatch.observer/filing/0001193125-26-248897.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/931148/000119312526248897/0001193125-26-248897-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/931148/000119312526248897/d158839d8k.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-248680","ticker":"TNYA","company_name":"Tenaya Therapeutics, Inc.","filed_at":"2026-05-29T21:04:54+00:00","headline":"Tenaya shareholders approve amended equity plan adding 6.5M shares, elect directors","event_type":"other_material","sec_items":["5.02","5.07","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 5.07, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-248680","json":"https://secwatch.observer/filing/0001193125-26-248680.json","markdown":"https://secwatch.observer/filing/0001193125-26-248680.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526248680/0001193125-26-248680-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526248680/tnya-20260527.htm"},"side_by_side_evidence":null},{"accession":"0001493152-26-026415","ticker":"CLDI","company_name":"Calidi Biotherapeutics, Inc.","filed_at":"2026-05-29T21:00:24+00:00","headline":"Calidi Biotherapeutics issues amended warrant for 17.4M shares at $0.23, subject to stockholder approval","event_type":"other_material","sec_items":["1.01","3.02","9.01"],"materiality_score":0.45,"calibrated_materiality_score":0.45,"match_reasons":["same SEC item: 1.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026415","json":"https://secwatch.observer/filing/0001493152-26-026415.json","markdown":"https://secwatch.observer/filing/0001493152-26-026415.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855485/000149315226026415/0001493152-26-026415-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855485/000149315226026415/form8-k.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}